Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection

Pathology and Oncology Research

Volumn 5, Issue 2, 1999, Pages 95-103

  Nair, Prapid ^a   Nair, Krishnan M ^a   Jayaprakash, Puthuveetil G ^a   Pillai, Radhakrishna M ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

Apoptosis; Cervical cancer; HPV

Indexed keywords

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; GENE INACTIVATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PAPILLOMA VIRUS; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; UTERINE CERVIX MUCOSA; VIRUS INFECTION;

EID: 0032781685     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1053/paor.1999.0161     Document Type: Article

References (34)

1. Bosch F X, Manos M M, Munoz N. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 87:1995;796-802.
2. Cotter T G, Samali A. Oncogenes, apoptosis and cancer. Forum Trends Exp Clin Med. 7:1997;4-17.
3. Furuya H, Yaboshita H, Noguchi M. Apoptosis and cell growth fraction in normai, dysplastic and neoplastic squamous epithelium of uterine cervix. Nippon Rinsha. 54:1996;1916-1921.
4. Guchelaar H J, Vermes A, Vermes I. Apoptosis: Molecular mechanisms and implications for cancer chemotherapy. Pharmacy World and Science. 19:1997;119-125.
5. Isacson C, Kessis T D, Hedrick L. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 56:1996;669-674.
6. Jayant K, Rao R S, Nene B M. Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. Int J Cancer. 63:1995;161-163.
7. Kagawa S, Fujiwara T, Hizuta A. P53 expression overcomes p21 (WAF1/ CIP1)-mediated G-1 arrest. Oncogene. 15:1997;1903-1909.
8. Kerr J FR, Winterford C M, Harmon B V. Apoptosis: Its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
9. Kesari A L, Chellam V G, Nair P P. Expression of the anti-apoptotic protein bcl-2 is not dependent on the tumor suppressor protein p53 in Indian breast carcinoma. Pathobiol. 65:1997;108-112.
10. Kurvinen K, Tervahauta A, Syrjanen S. The state of the p53 gene in human papillomavirus (HPV)- positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing. Anticancer Res. 14:1994;177-181.
11. Lakshmi S, Nair B S, Jayaprakash P G. P53 protein and tumorigenesis in the uterine cervix. Gen Diag Pathol. 142:1997;281-287.
12. Lane D P. p53, guardian of the genome. Nature. 358:1992;15-16.
13. Lechner M S, Mack D H, Finicle A B. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:1992;3045-3052.
14. Liang X H, Volkmann M, Klein R. Co-localization of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene. 8:1993;2645-2652.
15. Matlashewski, G, 1996, Human papillomavirus update, 15th Annual Intemational Papillomavirus Workshop, Gold Coast Australia, 1996.
16. Mietz J A, Unger T, Huibregtse J M. The transcriptional transactivation function of wild type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:1992;5013-5020.
17. Miyashita T, Krajewski S, Krajewska M. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
18. Nelson W G, Kastan M B. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol. 14:1994;1815-1823.
19. Pan H, Yin C, Van-Dyke T. Apoptosis and cancer mechanisms. Cancer Surveys. 29:1997;305-327.
20. Picksley S M, Lane D P. p53 and Rb, their cellular roles. Curr Opin Cell Biol. 6:1994;853-858.
21. Pillai M R, Kesari A L, Chellam V G. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, bcl-2, hormone receptors and tumor proliferation. Pathology Res Pract (in press). 1998.
22. Pillai R, Halabi S, McKalip A. The Presence of Human Papillomavirus 16/18 E6, p53 and Bcl-2 protein in cervicovagina) smears from patients with invasive cervical cancer. Cancer Epidemiol, Biomark Prevent, 5:1996;329-335.
23. Ravi D, Nalinakumari K R, Rajaram R S. Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Letters. 105:1996;139-146.
24. Ravi D, Ramdas K, Mathew B S. Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Eur J Cancer Part II, Oral Oncol (in press). 1998.
25. Reihsaus E, Kohler M, Kraiss S. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene. 5:1990;137-145.
26. Sanchez-Perez A M, Soriano S, Clarke A R. Disruption of the human papillomavirus type 16 E2 gene protects cervica! carcinoma cells from E2F-induced apoptosis. J General Virol. 78:1997;3009-3018.
27. Sheets E, Crum C P, Yeh J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labelling. Gynecol Oncol. 63:1996;94-100.
28. Shibata D K, Arnheim N, Martin W J. Detection of human papilloma virus in paraffin embedded tissue using the polymerase chain reaction. J Exp Med. 167:1988;225-230.
29. Shoji Y, Saegusa M, Takano Y. Correlation of apoptosis with tumor cell differentiation, progression and HPV infection in cervical carcinoma. J Clin Pathol. 49:1996;134-138.
30. Sidransky D, Hollstein M. Clinical implications of the p53 gene. Annu Rev Med. 47:1996;285-301.
31. Srinivas G, Kusumakumary P, Nair M K. BCL-2 protein and apoptosis in paediatric acute lymphoblastic leukaemia. Internat J Mol Med (in press). 1998.
32. Takahashi R. Role of p53 tumor suppressor gene and Fas I Apo-1 in induction of apoptosis and differentiation of cancer cells. Leukemia. 11:1997;331-333.
33. Ting Y, Manos M M. Detection and typing of genital human papillomavirus, in PCR protocols: A Guide to Methods and Applications, 1990;Academic Press, New York. p. 356-367.
34. Wang T T. Differential effects of chemotherapeutic agents on bcl-2/bax apoptosis pathway in breast cancer cell. Proc Annu Meet Am Assoc Cancer Res. 38:1997;769-769.